vimarsana.com

Latest Breaking News On - Head of preclinical development - Page 2 : vimarsana.com

Scottish Biotech ILC Therapeutics Sets Sights on Series A and IPO After Recent Investment Round

ILC's Alfacyte product has potential to become a game-changing antiviral treatment in the ongoing global fight against Covid-19 Scottish biotech ICL Therapeutics has set its sights on a Series A round

Glasgow
Glasgow-city
United-kingdom
Belgium
Scotland
Alan-walker
Robert-kopple
Peter-bains
Head-of-preclinical-development
Department-of-immunology
University-of-strathclyde
Business-wire

Sensorion Announces Candidate Selection for GJB2 Gene Therapy Program

Sensorion Announces Candidate Selection for GJB2 Gene Therapy Program
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Japan
France
Washington
United-states
Paris
France-general
Charenton
America
Institut-pasteur
Christine-petit
Necker-enfants-malades
Natalie-loundon

Sensorion Announces Agenda For R&D Day Showcasing Gene Therapy For Inner Ear Disease

Thursday April 6, 2023, at 8am EDT, 2pm CEST Regulatory News: Sensorion, (FR0012596468 ALSEN) a pioneering clinical-stage biotechnology company, specialising in the development of novel therapies

United-states
Paris
France-general
France
Washington
Charenton
America
Dennis-riedl
Christine-petit
Institut-pasteur
Barbara-kelley
Necker-enfants-malades

ContraFect Announces Multiple Presentations of New Data Demonstrating the Potential of Its Direct Lytic Agents (DLAs) to Address Antimicrobial Resistance at the 32nd Annual ECCMID Meeting

ContraFect Announces Multiple Presentations of New Data Demonstrating the Potential of Its Direct Lytic Agents (DLAs) to Address Antimicrobial Resistance at the 32nd Annual ECCMID Meeting
forextv.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from forextv.com Daily Mail and Mail on Sunday newspapers.

Portugal
Lisbon
Lisboa
Dario-lehoux
Jules-abraham
Michael-messinger
Exchange-commission
Head-of-preclinical-development
Contrafect-corporation-nasdaq
European-congress
Linkedin
Contrafect-corporation
© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.